Pharma Insights - Thought Leadership from Marketers | Sponsored Content | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Merck’s Sanat Chattopadhyay called for stronger leadership, data-driven oversight, and shared accountability to raise pharmaceutical quality standards. Susan J. Schniepp, Distinguished Fellow, ...

David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.

Jeffrey C. Mocny, PhD, of Abzena, and Anna McMahon, MS, of Cellares, discuss how biopharmaceutical risk-based standards accelerate innovation and speed-to-market by leveraging data for better patient ...

Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

Kent Malmros is senior director of training at Veeva Systems. He has spent the majority of his career delivering technology-enabled training solutions to life-sciences companies and has held ...

In this Drug Digest episode, Abzena’s vice president of Regulatory Strategy, Jeff Mocny, and Cellares’ director of Regulatory Affairs, Anna McMahon, examine how evolving regulatory and quality ...

Ryan Swanson, PhD, director of process development, Lifecore Biomedical, connected with PharmTech to discuss the formulation ...

PPD, explains how mixed FSP/FSO models help sponsors balance speed, cost, and complexity in clinical trial outsourcing.

Schmitt and Schniepp stress that merely citing a standard (e.g., "we followed GAMP") doesn't guarantee compliance. According ...

Accelerated approval relies on cornstarch-reduction as a surrogate endpoint, with crossover follow-up planned at 96 and 144 ...